The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments. IBM: International Business Machines . . . or “Incredible ...

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum computing’s promise in medicine. While Moderna isn’t looking to replace ...

Per the agreement, IBM will give Moderna access to quantum computing systems and provide the company with support and expertise as it explores quantum approaches to drug development. In particular, ...

Moderna and IBM are joining forces to incorporate artificial intelligence (AI) and quantum computing into mRNA development, which was used to create Moderna’s COVID-19 vaccine. “We are … ...

Now, moving along to the IBM deal. IBM says its generative AI for therapeutics could help Moderna researchers learn more about how molecules behave -- and this may help them design new ones.

Vaccine maker Moderna and computing giant IBM are teaming up to explore how quantum computing and artificial intelligence can develop future mRNA medicines, both companies announced on Thursday ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...

Boehringer will harness an AI model trained at IBM as the Big Pharma becomes the latest to apply machine learning tools to its drug development.

IBM has debuted a free AI platform designed to cut the cost and time associated with module synthesis and drug discoveries, a potentially powerful tool in the fight against COVID-19. As the novel ...

IBM and Moderna agree to pilot blockchain and cloud technologies to improve Covid-19 vaccine ... IBM also made its IBM Clinical Development tool available to trial sponsor organizations, ...

Moderna and IBM have announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management.

Can This AI Deal With IBM Be a Game-Changer for Moderna? By Adria Cimino – Apr 22, 2023 at 6 ... Efficiency, speed, and precision all are very important in drug and vaccine development.